ResMed

Health Care Health Care Equipment San Diego, California Last filing Aug 13, 2026 · FY2026

                    Revenue
                    FY2026
                
$5.7B
                    3y CAGR +10.2%
                    
                    P80
                    
                    +9.9%
                    
                    Net income
                    FY2026
                
$1.5B
                    Net margin +26.9%
                    
                    P100
                    
                    +8.8%
                    
                    Total assets
                    FY2026
                
$9.0B
                    ROA +17.0%
                    
                    P100
                    
                    +9.7%
                    
                    Operating cash flow
                    FY2026
                
$1.8B
                    FCF margin +29.2%
                    
                    P100
                    
                    +3.1%

18 yrs · FY2009–FY2026 9 filed · 0 derived · 0 blank

1Y 3Y 5Y 10Y

Dollars % of revenue % of assets YoY % CAGR

Each cell as a share of that year’s revenue.

Balance Sheet

Assets, liabilities, and equity

34 accounts · 3 years

Total assets $9.0B

Total liabilities $2.4B

Shareholders equity $6.6B

Account	2026	2025	2024
Assets
Cash and Cash Equivalents	26.0%	23.5%	5.1%
Accounts Receivable	18.3%	18.3%	17.9%
Inventory	16.7%	18.0%	17.5%
Prepaid Expenses	7.4%	8.3%	9.8%
Other Current Assets	8.1%	0.0%	—
Total Current Assets	76.5%	68.1%	50.3%
Property,Plant and Equipment	10.3%	10.7%	11.7%
Operating Lease Assets	2.7%	3.3%	3.2%
Goodwill	51.5%	59.2%	60.7%
Intangible Assets	8.0%	9.0%	10.4%
Deferred Tax Assets	5.8%	4.9%	4.3%
Other Noncurrent Assets	3.8%	3.6%	6.1%
Total Assets	158.6%	158.8%	146.7%
Liabilities
Accounts Payable	5.5%	5.4%	5.1%
Accrued Liabilities	10.5%	10.4%	10.4%
Deferred Revenue	2.9%	3.2%	3.3%
Current Portion of Long Term Debt	4.6%	0.2%	0.2%
Operating Lease Liabilities	0.5%	0.6%	0.5%
Other Current Liabilities	0.7%	0.0%	—
Total Current Liabilities	24.7%	19.8%	19.4%
Long Term Debt	7.1%	12.8%	14.9%
Deferred Revenue Noncurrent	3.0%	3.0%	2.9%
Operating Lease Liabilities Noncurrent	2.4%	3.0%	3.0%
Deferred Tax Liabilities	1.1%	1.5%	1.7%
Other Noncurrent Liabilities	3.8%	2.7%	0.9%
Total Liabilities	42.1%	42.9%	42.9%
Equity
Preferred Stock	0.0%	0.0%	0.0%
Common Stock	0.0%	0.0%	0.0%
Additional Paid In Capital	38.7%	39.5%	40.5%
Retained Earnings	128.3%	118.2%	106.5%
Treasury Stock	49.5%	40.3%	37.8%
Accumulated Other Comprehensive Income	-1.5%	-1.5%	-5.4%
Total Stockholders Equity	116.5%	116.0%	103.8%
Total Liabilitiesand Equity	158.6%	158.8%	146.7%

Income Statement

Revenue, expense, and profitability

17 accounts · 3 years

Revenue $5.7B

Operating income $1.9B

Net income $1.5B

Account	2026	2025	2024
IncomeStatement
Revenues Total Revenue	100.0%	100.0%	100.0%
Expenses Cost of Revenue	38.9%	40.6%	43.3%
Other Income Expense Gross Profit	61.1%	59.4%	56.7%
Expenses Research and Development	6.7%	6.4%	6.6%
Expenses Selling,General and Administrative	19.8%	19.3%	19.6%
Expenses Depreciation and Amortization	0.8%	0.9%	1.0%
Expenses Restructuring and Asset Impairment	0.4%	0.0%	1.4%
Expenses Operating Expenses	27.7%	26.6%	28.5%
Other Income Expense Operating Income	33.4%	32.7%	28.2%
Other Income Expense Other Income/expense	0.6%	-0.2%	-1.2%
Other Income Expense Income Before Tax	34.0%	32.6%	27.0%
Income Tax Income Tax Expense	7.0%	5.4%	5.2%
net Income net Income	26.9%	27.2%	21.8%
net Income Comprehensive Income	26.8%	30.7%	22.2%
Earnings Per Share Basic Eps	0.0%	0.0%	0.0%
Earnings Per Share Diluted Eps	0.0%	0.0%	0.0%
Earnings Per Share Weighted Average Shares Diluted	2.6%	2.9%	3.1%

Cash Flow Statement

Operating, investing, and financing flows

22 accounts · 3 years

Operating cash flow $1.8B

Investing cash flow $-545.2M

Financing cash flow $-1.0B

Account	2026	2025	2024
CashFlow
Operating Activities net Income	26.9%	27.2%	21.8%
Operating Activities Depreciation and Amortization	4.3%	4.6%	4.6%
Operating Activities Stock Based Compensation	1.8%	1.8%	1.7%
Operating Activities Changes In Operating Assets and Liabilities	-1.3%	0.3%	1.0%
Operating Activities Other Non Cash Items	0.1%	0.1%	0.8%
Operating Activities net Cash From Operating Activities	31.9%	34.0%	29.9%
Investing Activities Capital Expenditures	-2.8%	-1.7%	-2.1%
Investing Activities Business Acquisitions	0.0%	0.0%	0.0%
Investing Activities Purchases of Investments	-0.5%	-0.1%	-0.3%
Investing Activities Proceeds From Sale of Investments	0.0%	0.1%	0.0%
Investing Activities Other Investing Activities	-0.2%	0.6%	-0.5%
Investing Activities net Cash From Investing Activities	-9.6%	-3.9%	-5.8%
Financing Activities Proceeds From Debt	0.0%	0.0%	2.2%
Financing Activities Repayment of Debt	-0.2%	-0.8%	-17.8%
Financing Activities Repurchase of Common Stock	-12.4%	-5.8%	-3.2%
Financing Activities Dividends Paid	-6.2%	-6.0%	-6.0%
Financing Activities Proceeds From Stock Issuance	1.3%	1.4%	1.1%
Financing Activities Tax Withholding On Stock Based Compensation	-0.4%	-0.4%	-0.2%
Financing Activities Other Financing Activities	0.0%	-0.2%	-0.0%
Financing Activities net Cash From Financing Activities	-17.8%	-11.8%	-23.9%
Cash Reconciliation Effect of Exchange Rate On Cash	0.1%	0.5%	-0.0%
Cash Reconciliation net Change In Cash	4.6%	18.9%	0.2%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 3 years

Ratio	2026	2025	2024
Profitability
Gross margin	+61.1%	+59.4%	+56.7%
Operating margin	+33.4%	+32.7%	+28.2%
Net margin	+26.9%	+27.2%	+21.8%
FCF margin	+29.2%	+32.3%	+27.8%
Growth
Revenue CAGR (3y)	+10.2%	+12.9%	+13.6%
Returns
ROE	+23.1%	+23.5%	+21.0%
ROA	+17.0%	+17.1%	+14.9%
ROIC	+25.9%	+25.9%	+20.0%
Liquidity
Current ratio	3.10x	3.44x	2.59x
Quick ratio	1.80x	2.11x	1.18x
Leverage
D/E	0.36x	0.37x	0.41x
Interest coverage	—	—	—
Efficiency
Asset turnover	0.63x	0.63x	0.68x
Cash conversion cycle	+172d	+180d	+170d

Valuation

Price against fundamentals

FY2026 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched

ResMed

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Recent price history